Imatinib mesylate (Glivec) - Blast phase Initial PBS authority application Supporting information form (PB143)

For use in the treatment of blast phase of chronic myeloid leukaemia. You must lodge this form for a patient undergoing initial treatment in the blast phase of chronic myeloid leukaemia.

Page last updated: 11 July 2016

This information was printed Saturday 1 October 2016 from humanservices.gov.au/health-professionals/forms/pb143 It may not include all of the relevant information on this topic. Please consider any relevant site notices at humanservices.gov.au/siteinformation when using this material.